Management of advanced prostate cancer in Hong Kong: Insights from an APCCC‐Derived survey-Reference-Cited by-同舟云学术

Management of advanced prostate cancer in Hong Kong: Insights from an APCCC‐Derived survey

Published:2019-10 Issue:S6 Volume:15 Page:8-13
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Poon Darren Ming‐Chun¹,Ma Wai‐Kit²,Chan Tim‐Wai³,Ho Franklin Kwok‐Leung⁴,Ho Lap‐Yin⁵,Leung Angus Kwong‐Chuen⁶,Leung Simon Yiu‐Lam⁷,Sze Henry Chun‐Kin⁸,Kwong Philip Wai‐Kay⁹,Chan Eddie Shu‐Yin¹⁰

Affiliation:

1. State Key Laboratory of Translational OncologyDepartment of Clinical OncologySir YK Pao Centre for CancerHong Kong Cancer Institute and Prince of Wales HospitalChinese University of Hong Kong Shatin Hong Kong

2. Department of SurgeryQueen Mary HospitalUniversity of Hong Kong Pok Fu Lam Hong Kong

3. Department of Clinical OncologyQueen Elizabeth Hospital Kowloon Hong Kong

4. Medicare Group Medical Centre Units 2607, 2610–11, 26/F, Miramar Tower, 132 Nathan Road, Tsim Sha Tsui Kowloon Hong Kong

5. Asia Clinic Kowloon Hong Kong

6. AMO Oncology Centre Kowloon Hong Kong

7. Central Urology Clinic Kowloon Hong Kong

8. HEAL Oncology Unit 16C, Entertainment Building, 30 Queen's Road Central Hong Kong

9. Hong Kong Integrated Oncology Centre Central Hong Kong

10. Specialists Central Unit 2503–05, The Galleria, No. 9 Queen's Road Central Central Hong Kong

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13247

Reference15 articles.

1. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

2. Management of patients with advanced prostate cancer in the Asia Pacific region: ‘real-world’ consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017

3. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

5. Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone-naïve prostate cancer: The first real-life experience in Asia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Análisis espacial de mortalidad por cáncer de próstata y su relación con el acceso geográfico a los servicios de salud por cantón en Costa Rica, 2010-2016;Revista Geográfica de América Central;2024-01-04

2. Multicenter study on multidisciplinary committees in advanced prostate cancer;Actas Urológicas Españolas (English Edition);2022-03

3. Estudio multicéntrico sobre los comités multidisciplinarios en cáncer de próstata avanzado;Actas Urológicas Españolas;2021-11

4. A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer;World Journal of Urology;2020-06-04